UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Blockade of LAG-3 and PD-1 leads to co-expression of cytotoxic and exhaustion gene modules in CD8+ T cells to promote antitumor immunity

Cell, 2024-08, Vol.187 (16), p.4373-4388.e15

2024

Volltextzugriff (PDF)

Phase I Trial of Regorafenib, Hydroxychloroquine, and Entinostat in Metastatic Colorectal Cancer

The oncologist (Dayton, Ohio), 2022-09, Vol.27 (9), p.716-e689

2022

Volltextzugriff (PDF)

Implementing Pharmacogenetic Testing in Gastrointestinal Cancers (IMPACT-GI): Study Protocol for a Pragmatic Implementation Trial for Establishing DPYD and UGT1A1 Screening to Guide Chemotherapy Dosing

Frontiers in oncology, 2022-07, Vol.12, p.859846

2022

Volltextzugriff (PDF)

Challenges in the Management of Patients With HER2-Amplified Colorectal Cancer

JCO oncology practice, 2022-08, Vol.18 (8), p.555-556

2022

Volltextzugriff (PDF)

Anemia in a young Guinean male

Clinical case reports, 2021-08, Vol.9 (8), p.e04593-n/a

2021

Volltextzugriff (PDF)

97856 Implementation of DPYD and UGT1A1 pharmacogenetic testing to guide chemotherapy dosing

Journal of clinical and translational science, 2021-03, Vol.5 (s1), p.103-104

2021

Volltextzugriff (PDF)

Niraparib plus nivolumab or niraparib plus ipilimumab in patients with platinum-sensitive advanced pancreatic cancer: a randomised, phase 1b/2 trial

The lancet oncology, 2022-08, Vol.23 (8), p.1009-1020

2022

Volltextzugriff (PDF)

Defining the Role of Neoadjuvant Therapy for Gastroesophageal Cancers

Advances in oncology (New York), 2024-05, Vol.4 (1), p.207-218

2024

Volltextzugriff (PDF)

A phase II study of anti-PD1 monoclonal antibody (Nivolumab) administered in combination with anti-LAG3 monoclonal antibody (Relatlimab) in patients with metastatic melanoma naive to prior immunotherapy in the metastatic setting

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.TPS10085-TPS10085

2020

Volltextzugriff (PDF)

A Case Report Of The Effects Of Chemotherapy On Post-heart-transplant Gene Expression Profiling

Journal of cardiac failure, 2023-04, Vol.29 (4), p.705-705

2023

Volltextzugriff (PDF)

Evolving standards of care for neoadjuvant and adjuvant therapy in esophageal, gastroesophageal junction, and gastric cncer

Clinical advances in hematology & oncology, 2021-12, Vol.19 (12), p.784-793

2021

Volltextzugriff (PDF)

Implementing DPYD/UGT1A1 testing to prevent treatment related adverse events (TRAE) in patients with gastrointestinal (GI) cancer: Results of a pragmatic implementation trial

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.10599-10599

2024

Volltextzugriff (PDF)

Randomized phase II evaluation of nivolumab (nivo), or relatlimab (rela), or combined nivo-rela lead-in followed by nivo-rela as first line therapy for patients (pts) with advanced melanoma (mel)

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.9525-9525

2024

Volltextzugriff (PDF)

A Randomized Phase Ib/II Study of Niraparib plus Nivolumab or Ipilimumab in Patients with Platinum-Sensitive Advanced Pancreatic Cancer

The lancet oncology, 2022-07, Vol.23 (8), p.1009-1020

2022

Volltextzugriff (PDF)

A randomized phase Ib/II study of niraparib (nira) plus nivolumab (nivo) or ipilimumab (ipi) in patients (pts) with platinum-sensitive advanced pancreatic cancer (aPDAC)

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.4021-4021

2022

Volltextzugriff (PDF)

Phase II study of nivolumab (nivo) with relatlimab (rela) in patients (pts) with first-line advanced melanoma: Early on-treatment major pathologic response on biopsy

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.9514-9514

2022

Volltextzugriff (PDF)

DPYD and UGT1A1 Pharmacogenetic Testing in Patients with Gastrointestinal Malignancies: An Overview of the Evidence and Considerations for Clinical Implementation

Pharmacotherapy, 2020-11, Vol.40 (11), p.1108-1129

2020

Volltextzugriff (PDF)

Phase I trial of regorafenib, hydroxychloroquine, and entinostat in metastatic colorectal cancer

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.e15580-e15580

2021

Volltextzugriff (PDF)

Relationship between pre-treatment organ-specific tumor burden (TB) and response to immunotherapy in advanced melanoma (MEL)

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e21507-e21507

2018

Volltextzugriff (PDF)

CD8+ T cells contribute to survival in COVID-19 patients with hematologic cancers

Nature medicine, 2021-05, Vol.27 (7), p.1280-1289

2021

Volltextzugriff (PDF)

Breast Mass and Lytic Bone Lesions : A Rare Presentation of Non-Hodgkin’s Lymphoma Arising in the Breast

Case reports in oncological medicine, 2013-01, Vol.2013 (2013), p.1-4

2013

Volltextzugriff (PDF)

Abstract 18874: Prognostic Importance of Pulmonary Hypertension Etiology by Invasive Hemodynamics in Patients With Severe Aortic Stenosis

Circulation (New York, N.Y.), 2015-11, Vol.132 (Suppl_3 Suppl 3), p.A18874-A18874

2015

Volltextzugriff (PDF)

Abstract 16640: Prognostic Importance of Pulmonary Hypertension Severity by Invasive Hemodynamics in Patients With Severe Aortic Stenosis

Circulation (New York, N.Y.), 2015-11, Vol.132 (Suppl_3 Suppl 3), p.A16640-A16640

2015

Volltextzugriff (PDF)

TCT-662 Prognostic Importance Of Pulmonary Hypertension Etiology By Invasive Hemodynamics In Patients With Severe Aortic Stenosis

Journal of the American College of Cardiology, 2015-10, Vol.66 (15), p.B271-B271

2015

Volltextzugriff (PDF)

HER2-Specific Affibody-Conjugated Thermosensitive Liposomes (Affisomes) for Improved Delivery of Anticancer Agents

Journal of liposome research, 2008-01, Vol.18 (4), p.293-307

2008

Volltextzugriff (PDF)

1 – 25 von 66

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(58)
Mit Volltextzugriff
(59)

Publikationsform

Sprache

Englisch
(66)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Blockade of LAG-3 and PD-1 leads to co-expression of cytotoxic and exhaustion gene modules in CD8+ T cells to promote antitumor immunity

Phase I Trial of Regorafenib, Hydroxychloroquine, and Entinostat in Metastatic Colorectal Cancer

Implementing Pharmacogenetic Testing in Gastrointestinal Cancers (IMPACT-GI): Study Protocol for a Pragmatic Implementation Trial for Establishing DPYD and UGT1A1 Screening to Guide Chemotherapy Dosing

Challenges in the Management of Patients With HER2-Amplified Colorectal Cancer

Anemia in a young Guinean male

97856 Implementation of DPYD and UGT1A1 pharmacogenetic testing to guide chemotherapy dosing

Niraparib plus nivolumab or niraparib plus ipilimumab in patients with platinum-sensitive advanced pancreatic cancer: a randomised, phase 1b/2 trial

Defining the Role of Neoadjuvant Therapy for Gastroesophageal Cancers

A phase II study of anti-PD1 monoclonal antibody (Nivolumab) administered in combination with anti-LAG3 monoclonal antibody (Relatlimab) in patients with metastatic melanoma naive to prior immunotherapy in the metastatic setting

A Case Report Of The Effects Of Chemotherapy On Post-heart-transplant Gene Expression Profiling

Evolving standards of care for neoadjuvant and adjuvant therapy in esophageal, gastroesophageal junction, and gastric cncer

Implementing DPYD/UGT1A1 testing to prevent treatment related adverse events (TRAE) in patients with gastrointestinal (GI) cancer: Results of a pragmatic implementation trial

Randomized phase II evaluation of nivolumab (nivo), or relatlimab (rela), or combined nivo-rela lead-in followed by nivo-rela as first line therapy for patients (pts) with advanced melanoma (mel)

A Randomized Phase Ib/II Study of Niraparib plus Nivolumab or Ipilimumab in Patients with Platinum-Sensitive Advanced Pancreatic Cancer

A randomized phase Ib/II study of niraparib (nira) plus nivolumab (nivo) or ipilimumab (ipi) in patients (pts) with platinum-sensitive advanced pancreatic cancer (aPDAC)

Phase II study of nivolumab (nivo) with relatlimab (rela) in patients (pts) with first-line advanced melanoma: Early on-treatment major pathologic response on biopsy

DPYD and UGT1A1 Pharmacogenetic Testing in Patients with Gastrointestinal Malignancies: An Overview of the Evidence and Considerations for Clinical Implementation

Phase I trial of regorafenib, hydroxychloroquine, and entinostat in metastatic colorectal cancer

Relationship between pre-treatment organ-specific tumor burden (TB) and response to immunotherapy in advanced melanoma (MEL)

CD8+ T cells contribute to survival in COVID-19 patients with hematologic cancers

Breast Mass and Lytic Bone Lesions : A Rare Presentation of Non-Hodgkin’s Lymphoma Arising in the Breast

Abstract 18874: Prognostic Importance of Pulmonary Hypertension Etiology by Invasive Hemodynamics in Patients With Severe Aortic Stenosis

Abstract 16640: Prognostic Importance of Pulmonary Hypertension Severity by Invasive Hemodynamics in Patients With Severe Aortic Stenosis

TCT-662 Prognostic Importance Of Pulmonary Hypertension Etiology By Invasive Hemodynamics In Patients With Severe Aortic Stenosis

HER2-Specific Affibody-Conjugated Thermosensitive Liposomes (Affisomes) for Improved Delivery of Anticancer Agents

Suchergebnisse filtern